Document Detail


Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure.
MedLine Citation:
PMID:  16144997     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Distinguishing ischemic from nonischemic origin in patients presenting with acute heart failure (AHF) not resulting from acute myocardial infarction has both therapeutic and prognostic implications. The aim of the study was to assess whether myocardial contrast echocardiography (MCE) can identify underlying coronary artery disease (CAD) as the cause of AHF. METHODS AND RESULTS: Fifty-two consecutive patients with AHF with no prior clinical history of CAD and no clinical evidence of acute myocardial infarction underwent resting echocardiography and MCE both at rest and after dipyridamole stress at a mean of 9+/-2 days after admission. All patients underwent coronary arteriography before discharge. Of the 52 patients, 22 demonstrated flow-limiting CAD (>50% luminal diameter narrowing). Sensitivity, specificity, and positive and negative predictive values of MCE for the detection of CAD were 82%, 97%, 95%, and 88%, respectively. Among clinical, ECG, biochemical, resting echocardiographic, and MCE markers of CAD, MCE was the only independent predictor of CAD (P<0.0001). Quantitative MCE demonstrated significantly (P<0.0001) lower myocardial blood flow velocity reserve in vascular territories subtended by >50% CAD (0.59+/-0.46) compared with patients with normal coronary arteries (1.99+/-1.00). However, myocardial blood flow velocity reserve in patients with no significant CAD was significantly (P=0.03) lower compared with control (2.91+/-0.41). Myocardial blood flow velocity reserve correlated significantly (P<0.0001) with increasing severity of CAD. CONCLUSIONS: MCE, which is a bedside technique, may be used to detect CAD in patients presenting with AHF without a prior history of CAD or evidence of acute myocardial infarction. Quantitative MCE may further risk-stratify patients with AHF but no CAD.
Authors:
Roxy Senior; Raj Janardhanan; Paramjit Jeetley; Leah Burden
Related Documents :
1157237 - Prognosis in medically-treated coronary artery disease: influence of ejection fraction ...
8407007 - Somatic and social prognosis of patients with angina pectoris and normal coronary arter...
9230147 - Identification of severe or extensive coronary artery disease in women by adenosine tec...
10484057 - Human lipoprotein lipase hindiii polymorphism in young patients with myocardial infarct...
15203267 - Prehospital delay in acute coronary syndrome--an analysis of the components of delay.
16290987 - Left ventricular remodeling after primary coronary angioplasty in patients treated with...
Publication Detail:
Type:  Evaluation Studies; Journal Article     Date:  2005-09-06
Journal Detail:
Title:  Circulation     Volume:  112     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-09-13     Completed Date:  2006-02-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1587-93     Citation Subset:  AIM; IM    
Affiliation:
Cardiovascular Division, Northwick Park Hospital, Harrow, England, UK. roxy.senior@virgin.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Cardiac Output, Low / etiology*,  physiopathology,  ultrasonography*
Case-Control Studies
Contrast Media*
Echocardiography* / standards
Feasibility Studies
Female
Humans
Logistic Models
Male
Middle Aged
Myocardial Ischemia / complications*
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Contrast Media

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acculturation and socioeconomic position as predictors of coronary calcification in a multiethnic sa...
Next Document:  Molecular profiling of heart endothelial cells.